They have already stated they are going to phase3. This is the 2b, call it what you want.
I would settle for MDVNs deal of $225m up front and 40% of earnings. In a $166m market cap company what would that do to the price. Remember there is a lot of govt money invested in Prana and it has takeover protection from the Aus Foreign Investment Review Board.
This has been a debate with CYTK. Assuming PBT2 achieves stat sig, why sell long term profit on the cheap? You'd be talking billions for millions. They have an open ATM, no need for partner, but no need for delays either.
Even PRAN management has stated they have to run a Phase 3 trial. This will have to be run in the U.S., will be very expensive, need a partner, then PRAN will not have full ownership and will probably only get royalties. And that's IF Phase 2 shows stat sig. Also, that's assuming they skip P2b.
I ain't so good with grammar so I quoted from Zhidao90 Oct 9 11:30pm to AdamFUDstain aka Peterharmisan when he was responding to him trying to compare PBT2 with Provenge. "If PBT2 is effective in the elderly, Prana won't have to work overtime to convince the US to approve it. The government will beg Prana to get it out there as quickly as possible. Every political force will be aligned in Prana's favor. Did you get the part of the presentation where Medicare and Medicaid go broke by the end of the decade - just due to AD alone! The boomers are about to be heard from once again, and that hasn't always been a good thing."
.......Why is it that Adamfartstain guy makes me want to scratch my #$%$ all the time?